Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,330,333
New position
Shares Held
17,539
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Integrated Wealth Concepts LLC holds $9,217,181 across 11 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
13,744 | $1,810,634 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
This page
|
17,539 | $1,330,333 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
2,127 | $1,261,268 | |
| 4 | VTRS |
Viatris Inc
|
79,212 | $1,070,154 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
40,282 | $910,373 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
15,086 | $894,147 | |
| 7 | ZTS |
Zoetis Inc.
|
7,517 | $888,584 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,468 | $646,616 |
All Filings in LNTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,330,333 | 17,539 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||